Prevention of type 1 diabetes: where do we start?
Pozzilli
P
P
Adorini
L
L
D000328:Adult; D000818:Animals; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D017252:CD3 Complex / Q000276:immunology; D018834:Chaperonin 60; D002648:Child; D002675:Child, Preschool; D003922:Diabetes Mellitus, Type 1 / Q000235:genetics / Q000276:immunology / Q000517:prevention & control*; D005819:Genetic Markers; D020022:Genetic Predisposition to Disease; D006801:Humans; D007231:Infant, Newborn; D051379:Mice; D010446:Peptide Fragments; D010455:Peptides / Q000627:therapeutic use; D011322:Primary Prevention; D053220:Receptors, TNF-Related Apoptosis-Inducing Ligand; D018124:Receptors, Tumor Necrosis Factor / Q000235:genetics; D053219:Receptors, Tumor Necrosis Factor, Member 25
D000911:Antibodies, Monoclonal; D017252:CD3 Complex; D018834:Chaperonin 60; C447781:DiaPep 277; D005819:Genetic Markers; D010446:Peptide Fragments; D010455:Peptides; D053220:Receptors, TNF-Related Apoptosis-Inducing Ligand; D018124:Receptors, Tumor Necrosis Factor; D053219:Receptors, Tumor Necrosis Factor, Member 25; C105190:TNFRSF10A protein, human; C506033:TNFRSF25 protein, human; C506034:Tnfrsf25 protein, mouse